A carregar...

Randomized Controlled Trial of Adalimumab in Patients With Nonpsoriatic Peripheral Spondyloarthritis

OBJECTIVE: To evaluate the efficacy and safety of adalimumab in patients with active nonpsoriatic peripheral spondyloarthritis (SpA). METHODS: ABILITY-2 is an ongoing phase III, multicenter study of adalimumab treatment. Eligible patients age ≥18 years fulfilled the Assessment of SpondyloArthritis i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Arthritis Rheumatol
Main Authors: Mease, Philip, Sieper, Joachim, Van den Bosch, Filip, Rahman, Proton, Karunaratne, P Mahinda, Pangan, Aileen L
Formato: Artigo
Idioma:Inglês
Publicado em: BlackWell Publishing Ltd 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4409087/
https://ncbi.nlm.nih.gov/pubmed/25545240
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.39008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!